Sort
8,912 grants matching “sars cov 2”
Task C11: Using a Human Lung Microphysiologic System to Model SARS-CoV-2 Infection and Test Candidate Countermeasures
$470,308David Beasley · University Of Texas Med Br Galveston · N01 · FY2020 · AI
NICHD Global Network for Womenâs and Childrenâs Health Research: Research Units
$470,273William A Petri · University Of Virginia · UG1 · FY2025 · HD
Scramblases for protein glycosylation
$470,047Anant K Menon · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · GM
Scramblases for protein glycosylation
$470,047Anant K Menon · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · GM
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
$469,477Monica Kraft · University Of Arizona · U19 · FY2023 · AI
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
$469,443Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2023 · AI
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
$469,443Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2024 · AI
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
$468,938Chang Liu · Johns Hopkins University · DP2 · FY2023 · AI
Prediction of Major Adverse Kidney Events and Recovery (Pred-MAKER) in COVID-19 Patients
$468,762Evren U. Azeloglu · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
STUDIES OF A SARS-CORONAVIRUS RECEPTOR
$468,555Michael R. Farzan · Harvard Medical School · R01 · FY2008 · AI
CRISPR-Cas13-based rapid HIV-1 test
$468,545Peter B Lillehoj · Rice University · R61 · FY2023 · AI
NOX1 and NOX2 as Therapeutic Targets in Influenza
$468,000J. David Lambeth · Emory University · R33 · FY2014 · AI
Equipment to facilitate expansion of MMRRC services related to gut microbiota and infectious diseases including SARS-CoV-2 and future infectious agents
$467,993Craig L Franklin · University Of Missouri-Columbia · U42 · FY2021 · OD
Structural and functional studies of polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts)
$467,822Nadine Samara · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
Special Mouse Strains Resource
$467,220Laura G Reinholdt · Jackson Laboratory · P40 · FY2021 · OD
Single Cell Core
$467,031Peter Alan Sims · Columbia University Health Sciences · U19 · FY2025 · AI
Tissue Engineering Resource Center
$467,004Gordana Vunjak-Novakovic · Columbia University Health Sciences · P41 · FY2020 · EB
Enhancing the utility of deer mice as an infectious disease model
$466,725Hippokratis Kiaris · University Of South Carolina At Columbia · R24 · FY2025 · AI
Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogens
$466,539Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2025 · AI
Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2
$466,500Suzie H Pun · University Of Washington · U01 · FY2021 · AA
Facilitation of Post-Acute Sequela to COVID Studies in Mouse Models
$466,389Craig L Franklin · University Of Missouri-Columbia · U42 · FY2021 · OD
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$466,316Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Accurate prediction of neutralization capacity from deep mining of SARS-CoV-2 serology
$466,125Shohei Koide · New York University School Of Medicine · R21 · FY2020 · AI
ADE-minimized COVID-19 vaccine via epitope focusing and anti-inflammatory innate immunity
$466,125Timothy J Cardozo · New York University School Of Medicine · R21 · FY2020 · AI
Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inference
$465,948Marc A. Suchard · University Of California Los Angeles · R01 · FY2022 · AI